Literature DB >> 2783485

Identification of murine complement receptor type 2.

J D Fingeroth1, M A Benedict, D N Levy, J L Strominger.   

Abstract

A rabbit antiserum reactive with the human complement component C3d/Epstein-Barr virus receptor (complement receptor type 2, CR2) immunoprecipitates a Mr 155,000 murine B-cell surface antigen. The apparent molecular weight and cellular distribution of this murine antigen are similar to those of human CR2. Cells expressing the murine protein bind sheep erythrocytes coated with antibody and murine C1-C3d but do not bind Epstein-Barr virus at all. The monospecific antiserum to human CR2 together with goat F(ab')2 anti-rabbit IgG blocks attachment of the C3d-coated erythrocytes to receptor-bearing murine B lymphocytes. To further characterize murine CR2, a lambda gt11 library from the murine late pre-B-cell line 70Z/3 was screened with human CR2 cDNA. A partial cDNA clone of 3.5 kilobases with 79% amino acid sequence identity to human CR2 in the unique intracytoplasmic region and 63% identity to the sixth human CR2 repeat was obtained. Blot hybridization with the murine cDNA clone identified an RNA species of approximately 4.7 kilobases, similar in size to human CR2 mRNA, from a murine B-cell line but not from a murine T-cell line.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783485      PMCID: PMC286440          DOI: 10.1073/pnas.86.1.242

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Formation of disulphide-linked mu 2 omega 2 tetramers in pre-B cells by the 18K omega-immunoglobulin light chain.

Authors:  S Pillai; D Baltimore
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

2.  Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes.

Authors:  M D Moore; N R Cooper; B F Tack; G R Nemerow
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative.

Authors:  T Kinoshita; J Takeda; K Hong; H Kozono; H Sakai; K Inoue
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

4.  Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production.

Authors:  M K Hostetter
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

5.  Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21).

Authors:  J D Fingeroth; M L Clabby; J D Strominger
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

6.  Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs.

Authors:  K M O'Neil; H D Ochs; S R Heller; L C Cork; J M Morris; J A Winkelstein
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

7.  Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: a type II membrane glycoprotein involved in normal and neoplastic cell growth.

Authors:  E Quackenbush; M Clabby; K M Gottesdiener; J Barbosa; N H Jones; J L Strominger; S Speck; J M Leiden
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

8.  Characterization and expression of the human alpha beta T cell receptor by using a framework monoclonal antibody.

Authors:  M B Brenner; J McLean; H Scheft; R A Warnke; N Jones; J L Strominger
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

9.  Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.

Authors:  J J Weis; L E Toothaker; J A Smith; J H Weis; D T Fearon
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  Systemic autoimmune disease arises from polyclonal B cell activation.

Authors:  D M Klinman; A D Steinberg
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more
  16 in total

Review 1.  The role of complement in the acquired immune response.

Authors:  C H Nielsen; E M Fischer; R G Leslie
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

Review 2.  Molecular structure and expression of anthropic, ovine, and murine forms of complement receptor type 2.

Authors:  Dong Liu; Jian-Ying Zhu; Zhong-Xiang Niu
Journal:  Clin Vaccine Immunol       Date:  2008-04-09

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

4.  CD21-Dependent infection of an epithelial cell line, 293, by Epstein-Barr virus.

Authors:  J D Fingeroth; M E Diamond; D R Sage; J Hayman; J L Yates
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

5.  Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor.

Authors:  Javier G Ogembo; Lakshmi Kannan; Ionita Ghiran; Anne Nicholson-Weller; Robert W Finberg; George C Tsokos; Joyce D Fingeroth
Journal:  Cell Rep       Date:  2013-02-14       Impact factor: 9.423

6.  Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection.

Authors:  Mohamed S Arredouani; Manoj K Bhasin; David R Sage; Laura K Dunn; Michael B Gill; Deep Agnani; Towia A Libermann; Joyce D Fingeroth
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

7.  B-cell extrinsic CR1/CR2 promotes natural antibody production and tolerance induction of anti-alphaGAL-producing B-1 cells.

Authors:  Ichiro Shimizu; Toshiyasu Kawahara; Fabienne Haspot; Philip D Bardwell; Michael C Carroll; Megan Sykes
Journal:  Blood       Date:  2006-10-05       Impact factor: 22.113

8.  A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.

Authors:  Liudmila Kulik; Finnegan B Hewitt; Van C Willis; Rosa Rodriguez; Stephen Tomlinson; V Michael Holers
Journal:  Mol Immunol       Date:  2015-02       Impact factor: 4.407

9.  The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding.

Authors:  Andrea E Prota; David R Sage; Thilo Stehle; Joyce D Fingeroth
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

10.  Malaria inhibits surface expression of complement receptor 1 in monocytes/macrophages, causing decreased immune complex internalization.

Authors:  Cristina Fernandez-Arias; Jean Pierre Lopez; Jean Nikolae Hernandez-Perez; Maria Dolores Bautista-Ojeda; Oralee Branch; Ana Rodriguez
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.